Biodegradable intravitreal tyrosine kinase inhibitors implants

Details for Australian Patent Application No. 2005240093 (hide)

Owner Allergan, Inc.

Inventors Chang-Lin, Joan-En; Edelman, Jeffrey L.; Nivaggioli, Thierry; De Vries, Gerald; Malone, Thomas C.; Hughes, Patrick M.; Blanda, Wendy M.; Shiah, Jane, Guo; Spada, Lon T.

Agent Davies Collison Cave

Pub. Number AU-B-2005240093

PCT Pub. Number WO2005/107708

Priority 10/837,361 30.04.04 US

Filing date 29 April 2005

Wipo publication date 17 November 2005

Acceptance publication date 12 May 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/00 (2006.01)

A61K 31/404 (2006.01)

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/107708 Priority application(s): WO2005/107708

12 May 2011 Application Accepted

  Published as AU-B-2005240093

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240094-Compounds and compositions as Cathepsin S inhibitors

2005240092-Steroid intraocular implants having an extended sustained release for a period of greater than two months